The	O
MEssaging	O
for	O
Diabetes	O
Intervention	B:C0184661
Reduced	O
Barriers	O
to	O
Medication	O
Adherence	I:C2364172
Among	O
Low	O
-	I:C1331016
Income	I:C1331016
,	O
Diverse	O
Adults	O
With	O
Type	O
2	I:C0011860
.	O

The	O
MEssaging	O
for	O
Diabetes	O
Intervention	O
Reduced	O
Barriers	O
to	O
Medication	B:C2364172
Adherence	I:C2364172
Among	O
Low	O
-	I:C1331016
Income	I:C1331016
,	O
Diverse	O
Adults	O
With	O
Type	O
2	I:C0011860
.	O

The	O
MEssaging	O
for	O
Diabetes	O
Intervention	O
Reduced	O
Barriers	O
to	O
Medication	O
Adherence	I:C2364172
Among	O
Low	B:C1331016
-	I:C1331016
Income	I:C1331016
,	O
Diverse	O
Adults	O
With	O
Type	O
2	I:C0011860
.	O

The	O
MEssaging	O
for	O
Diabetes	O
Intervention	O
Reduced	O
Barriers	O
to	O
Medication	O
Adherence	I:C2364172
Among	O
Low	O
-	I:C1331016
Income	I:C1331016
,	O
Diverse	O
Adults	O
With	O
Type	B:C0011860
2	I:C0011860
.	O

Nonadherence	B:C0746935
to	O
diabetes	O
medication	O
is	O
prevalent	O
and	O
costly	O
.	O

Nonadherence	O
to	O
diabetes	B:C0011847
medication	O
is	O
prevalent	O
and	O
costly	O
.	O

Nonadherence	O
to	O
diabetes	O
medication	B:C2081612
is	O
prevalent	O
and	O
costly	O
.	O

MEssaging	O
for	O
Diabetes	O
(	O
MED	O
)	O
,	O
a	O
mobile	B:C2718080
health	I:C2718080
(	O
mobile	O
health	I:C2718080
)	O
intervention	O
,	O
identified	O
and	O
addressed	O
user	O
-	O
specific	O
barriers	O
to	O
medication	O
adherence	I:C2364172
.	O

MEssaging	O
for	O
Diabetes	O
(	O
MED	O
)	O
,	O
a	O
mobile	O
health	I:C2718080
(	O
mobile	B:C2718080
health	I:C2718080
)	O
intervention	O
,	O
identified	O
and	O
addressed	O
user	O
-	O
specific	O
barriers	O
to	O
medication	O
adherence	I:C2364172
.	O

MEssaging	O
for	O
Diabetes	O
(	O
MED	O
)	O
,	O
a	O
mobile	O
health	I:C2718080
(	O
mobile	O
health	I:C2718080
)	O
intervention	B:C0184661
,	O
identified	O
and	O
addressed	O
user	O
-	O
specific	O
barriers	O
to	O
medication	O
adherence	I:C2364172
.	O

MEssaging	O
for	O
Diabetes	O
(	O
MED	O
)	O
,	O
a	O
mobile	O
health	I:C2718080
(	O
mobile	O
health	I:C2718080
)	O
intervention	O
,	O
identified	O
and	O
addressed	O
user	B:C1706077
-	O
specific	O
barriers	O
to	O
medication	O
adherence	I:C2364172
.	O

MEssaging	O
for	O
Diabetes	O
(	O
MED	O
)	O
,	O
a	O
mobile	O
health	I:C2718080
(	O
mobile	O
health	I:C2718080
)	O
intervention	O
,	O
identified	O
and	O
addressed	O
user	O
-	O
specific	O
barriers	O
to	O
medication	B:C2364172
adherence	I:C2364172
.	O

We	O
assessed	O
whether	O
MED	O
reduced	O
users	B:C1706077
'	O
targeted	O
barriers	O
and	O
if	O
barrier	O
reductions	O
were	O
associated	O
with	O
within	O
-	I:C0679646
participant	I:C0679646
improvements	O
in	O
adherence	O
or	O
glycemic	O
control	O
(	O
HbA1	O
c	I:C0019018
)	O
.	O

We	O
assessed	O
whether	O
MED	O
reduced	O
users	O
'	O
targeted	O
barriers	O
and	O
if	O
barrier	O
reductions	O
were	O
associated	O
with	O
within	B:C0679646
-	I:C0679646
participant	I:C0679646
improvements	O
in	O
adherence	O
or	O
glycemic	O
control	O
(	O
HbA1	O
c	I:C0019018
)	O
.	O

We	O
assessed	O
whether	O
MED	O
reduced	O
users	O
'	O
targeted	O
barriers	O
and	O
if	O
barrier	O
reductions	O
were	O
associated	O
with	O
within	O
-	I:C0679646
participant	I:C0679646
improvements	O
in	O
adherence	O
or	O
glycemic	O
control	O
(	O
HbA1	B:C0019018
c	I:C0019018
)	O
.	O

Adults	O
(	O
N	O
=	O
80	O
)	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
completed	O
self	O
-	O
report	O
measures	O
identifying	O
barriers	O
to	O
adherence	O
at	O
baseline	O
and	O
monthly	O
for	O
3	O
months	O
.	O

At	O
each	O
assessment	B:C0220825
,	O
17	O
barriers	O
were	O
assessed	O
and	O
ranked	O
for	O
each	O
user	O
.	O

At	O
each	O
assessment	O
,	O
17	O
barriers	O
were	O
assessed	O
and	O
ranked	O
for	O
each	O
user	B:C1706077
.	O

Each	O
subsequent	O
month	O
,	O
users	B:C1706077
received	O
daily	O
text	O
messages	I:C3178910
addressing	O
their	O
3	O
highest	O
ranked	O
barriers	O
.	O

Each	O
subsequent	O
month	O
,	O
users	O
received	O
daily	O
text	B:C3178910
messages	I:C3178910
addressing	O
their	O
3	O
highest	O
ranked	O
barriers	O
.	O

Targeted	O
barriers	O
were	O
different	O
for	O
each	O
participant	B:C0679646
and	O
could	O
change	O
monthly	O
.	O

Paired	O
t-	B:C0871472
tests	I:C0871472
assessed	O
within	O
-	I:C0679646
participant	I:C0679646
improvement	O
in	O
targeted	O
barriers	O
each	O
month	O
,	O
and	O
nested	O
regression	O
models	I:C3161035
assessed	O
if	O
changes	O
in	O
a	O
participant	O
's	I:C0679646
barrier	O
scores	O
were	O
associated	O
with	O
improvements	O
in	O
adherence	O
and	O
HbA1	O
c	I:C0019018
.	O

Paired	O
t-	O
tests	I:C0871472
assessed	O
within	B:C0679646
-	I:C0679646
participant	I:C0679646
improvement	O
in	O
targeted	O
barriers	O
each	O
month	O
,	O
and	O
nested	O
regression	O
models	I:C3161035
assessed	O
if	O
changes	O
in	O
a	O
participant	O
's	I:C0679646
barrier	O
scores	O
were	O
associated	O
with	O
improvements	O
in	O
adherence	O
and	O
HbA1	O
c	I:C0019018
.	O

Paired	O
t-	O
tests	I:C0871472
assessed	O
within	O
-	I:C0679646
participant	I:C0679646
improvement	O
in	O
targeted	O
barriers	O
each	O
month	O
,	O
and	O
nested	O
regression	B:C3161035
models	I:C3161035
assessed	O
if	O
changes	O
in	O
a	O
participant	O
's	I:C0679646
barrier	O
scores	O
were	O
associated	O
with	O
improvements	O
in	O
adherence	O
and	O
HbA1	O
c	I:C0019018
.	O

Paired	O
t-	O
tests	I:C0871472
assessed	O
within	O
-	I:C0679646
participant	I:C0679646
improvement	O
in	O
targeted	O
barriers	O
each	O
month	O
,	O
and	O
nested	O
regression	O
models	I:C3161035
assessed	O
if	O
changes	O
in	O
a	O
participant	B:C0679646
's	I:C0679646
barrier	O
scores	O
were	O
associated	O
with	O
improvements	O
in	O
adherence	O
and	O
HbA1	O
c	I:C0019018
.	O

Paired	O
t-	O
tests	I:C0871472
assessed	O
within	O
-	I:C0679646
participant	I:C0679646
improvement	O
in	O
targeted	O
barriers	O
each	O
month	O
,	O
and	O
nested	O
regression	O
models	I:C3161035
assessed	O
if	O
changes	O
in	O
a	O
participant	O
's	I:C0679646
barrier	O
scores	O
were	O
associated	O
with	O
improvements	O
in	O
adherence	O
and	O
HbA1	B:C0019018
c	I:C0019018
.	O

Participants	B:C0679646
were	O
69	O
%	O
non-white	O
and	O
82	O
%	O
had	O
incomes	O
<	O
$	O
25	O
K	O
.	O

Average	O
HbA1c	B:C0019018
was	O
8.2	O
Â±	O
2.0	O
%	O
.	O

The	O
most	O
commonly	O
reported	O
barriers	O
were	O
the	O
cost	O
of	O
medications	B:C2081612
(	O
76	O
%	O
)	O
,	O
believing	O
medications	O
are	O
harmful	O
(	O
58	O
%	O
)	O
,	O
and	O
lacking	O
information	O
about	O
medications	O
(	O
53	O
%	O
)	O
.	O

The	O
most	O
commonly	O
reported	O
barriers	O
were	O
the	O
cost	O
of	O
medications	O
(	O
76	O
%	O
)	O
,	O
believing	O
medications	B:C2081612
are	O
harmful	O
(	O
58	O
%	O
)	O
,	O
and	O
lacking	O
information	O
about	O
medications	O
(	O
53	O
%	O
)	O
.	O

The	O
most	O
commonly	O
reported	O
barriers	O
were	O
the	O
cost	O
of	O
medications	O
(	O
76	O
%	O
)	O
,	O
believing	O
medications	O
are	O
harmful	O
(	O
58	O
%	O
)	O
,	O
and	O
lacking	O
information	O
about	O
medications	B:C2081612
(	O
53	O
%	O
)	O
.	O

Participants	B:C0679646
'	O
barrier	O
scores	O
improved	O
each	O
month	O
and	O
barrier	O
improvement	O
predicted	O
adherence	O
assessed	O
via	O
nightly	O
adherence	O
assessment	O
text	O
messages	I:C3178910
(	O
P	O
<	O
.001	O
)	O
.	O

Participants	O
'	O
barrier	O
scores	O
improved	O
each	O
month	O
and	O
barrier	O
improvement	O
predicted	O
adherence	O
assessed	O
via	O
nightly	O
adherence	O
assessment	O
text	B:C3178910
messages	I:C3178910
(	O
P	O
<	O
.001	O
)	O
.	O

Among	O
participants	B:C0679646
who	O
completed	O
assessments	O
each	O
month	O
,	O
barrier	O
improvement	O
in	O
months	O
2	O
and	O
3	O
(	O
P	O
<	O
.05	O
)	O
predicted	O
HbA1c	O
improvement	O
.	O

Among	O
participants	O
who	O
completed	O
assessments	O
each	O
month	O
,	O
barrier	O
improvement	O
in	O
months	O
2	O
and	O
3	O
(	O
P	O
<	O
.05	O
)	O
predicted	O
HbA1c	B:C0019018
improvement	O
.	O

Iterative	O
,	O
individual	O
tailoring	O
may	O
overcome	O
users	B:C1706077
'	O
barriers	O
to	O
adherence	O
.	O

Attrition	O
is	O
a	O
challenge	O
for	O
mobile	B:C2718080
health	I:C2718080
interventions	O
among	O
low	O
-	I:C1331016
income	I:C1331016
patients	O
.	O

Attrition	O
is	O
a	O
challenge	O
for	O
mobile	O
health	I:C2718080
interventions	B:C0184661
among	O
low	O
-	I:C1331016
income	I:C1331016
patients	O
.	O

Attrition	O
is	O
a	O
challenge	O
for	O
mobile	O
health	I:C2718080
interventions	O
among	O
low	B:C1331016
-	I:C1331016
income	I:C1331016
patients	O
.	O

